Drug Shortage Report for TEVA-SOLIFENACIN
Report ID | 151465 |
Drug Identification Number | 02397900 |
Brand name | TEVA-SOLIFENACIN |
Common or Proper name | SOLIFENACIN 5MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-12-14 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-11-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v40 | 2023-11-03 | French | Compare |
v39 | 2023-11-03 | English | Compare |
v38 | 2023-10-04 | French | Compare |
v37 | 2023-10-04 | English | Compare |
v36 | 2023-08-08 | French | Compare |
v35 | 2023-08-08 | English | Compare |
v34 | 2023-07-27 | French | Compare |
v33 | 2023-07-27 | English | Compare |
v32 | 2023-06-08 | French | Compare |
v31 | 2023-06-08 | English | Compare |
v30 | 2023-04-27 | French | Compare |
v29 | 2023-04-27 | English | Compare |
v28 | 2023-02-16 | French | Compare |
v27 | 2023-02-16 | English | Compare |
v26 | 2023-01-19 | French | Compare |
v25 | 2023-01-19 | English | Compare |
v24 | 2022-12-01 | French | Compare |
v23 | 2022-12-01 | English | Compare |
v22 | 2022-11-14 | French | Compare |
v21 | 2022-11-14 | English | Compare |